Helminth Glycans at the Host-Parasite Interface and Their Potential for Developing Novel Therapeutics by Myrna J. M. Bunte, Arjen Schots, Jan E. Kammenga, Ruud H. P. Wilbers

“…Helminths are parasitic worms that have successfully co-evolved with their host immune system to sustain long-term infections. …”
Get full text

Glyco-Engineering Plants to Produce Helminth Glycoproteins as Prospective Biopharmaceuticals: Recent Advances, Challenges and Future Prospects by Alex van der Kaaij, Kim van Noort, Pieter Nibbering, Ruud H. P. Wilbers, Arjen Schots

“…The majority of biopharmaceuticals are based on human glycoproteins, but non-human glycoproteins, originating from for instance parasitic worms (helminths), form an untapped pool of potential therapeutics for immune-related diseases and vaccine candidates. …”
Get full text